Results 81 to 90 of about 21,457 (218)
Intrapetrous internal carotid artery dissection and essential thrombocythemia: what relationship? A case report. [PDF]
Internal carotid artery (ICA) dissection is responsible for 10–20% of strokes in young and middleaged patients. Isolated ICA dissection involving the intrapetrous carotid canal is particularly rare, and no case has been reported to describe an ...
Gargiulo G +18 more
core +1 more source
Essential thrombocythemia and acute myocardial infarction treated with rescue coronary angioplasty
A 48-year-old man with essential thrombocythemia suffered an extensive anterior acute myocardial infarction; this is a rare association. A pharmacological thrombolysis was performed, without success.
Antonio Esteves Fº +4 more
doaj +1 more source
This Is Not a Myeloproliferative Neoplasm…
Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
Stephanie Juané Kennedy
wiley +1 more source
The risk of thrombosis is high in patients with essential thrombocythemia. Special precaution needed for those patients who will undergo Coronary artery bypass grafting. We are reporting a 62 years old patient with ischemic heart disease who was found to
Edem Ziadinov +3 more
doaj +1 more source
Calreticulin Type 26 Mutation in Myelofibrosis: A Rare Variant With Diagnostic Challenges
ABSTRACT Background Myeloproliferative neoplasms (MPNs) are clonal hematologic disorders commonly driven by mutations in JAK2, MPL, or CALR. Because routine CALR assays are largely optimized for the canonical Type 1 and Type 2 exon 9 variants, rare noncanonical mutations may be missed, creating diagnostic challenges.
Teresa Maltese +6 more
wiley +1 more source
Clonal evolution process from essential thrombocythemia to acute myeloid leukemia in the original patient from whom the CALR-mutated Marimo cell line was established [PDF]
We previously reported the Marimo cell line, which was established from the bone marrow cells of a patient with essential thrombocythemia (ET) at the last stage after transformation to acute myeloid leukemia (AML).
Ishikawa, Yuichi +6 more
core +1 more source
ABSTRACT Background Janus kinase inhibitors (JAKis), the current standard of care for myelofibrosis (MF), provide clinical benefit, but responses are frequently incomplete, non‐durable, and associated with cytopenias, underscoring the need for therapies with novel mechanisms of action.
Sebastian Grosicki +15 more
wiley +1 more source
A few types of myeloproliferative neoplasms may be significant for Janus-associated kinase 2 mutation, JAK2 V617F, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Muhammed Atere +4 more
doaj +1 more source
Walsh & Hoyt: Essential Thrombocythemia
Essential thrombocythemia (primary thrombocythemia, hemorrhagic thrombocythemia, idiopathic thrombocythemia) is a chronic myeloproliferative disorder in which the predominant laboratory feature is a persistent, striking thrombocytosis with elevation of ...
John Kerrison, MD
core

